A 64-year-old with advanced prostate cancer underwent robotic surgery after hormonal therapy, achieving successful tumour ...

Add Yahoo as a preferred source to see more of our stories on Google. A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth ...

ATLANTA, GA / ACCESS Newswire / April 17, 2026 / Advanced Urology , a leading provider of comprehensive urologic care in the ...

For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to luteinizing hormone-releasing hormone (LHRH) agonists as a ...

ADT intensification may not improve prostate cancer survival. Explore real-world findings and key risk factors. Read more.

—As more men are cured of prostate cancer, or are long-term survivors, the challenges of survivorship are in the spotlight. Improved screening practices, earlier detection, and better therapies have ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in Pharmacological Research, show that an innovative drug effectively prevents ...

Immunotherapies use the power of your immune system to fight your cancer. Vaccines are one form of immunotherapy. Sipuleucel-T is a vaccine used for advanced, metastatic prostate cancer if: It no ...

Add Yahoo as a preferred source to see more of our stories on Google. Joe Biden's Cancer Moonshot initiative had funded hundreds of cancer research projects across the country. AP Photo/Gerald Herbert ...

Drugs used for prostate cancer may not increase bleeding or clotting risks when used with blood thinners, thus providing ...

Among age-related ailments, cases of prostate-related problems are being reported with increasing frequency. Most concerning ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...